Skip to main content
. 2010 Dec 23;33(12):E7–E12. doi: 10.1002/clc.20634

Table 1.

Baseline Clinical and Angiographic Characteristic

Normal Flow Group (n = 169) Slow/No‐Reflow Group (n = 41) P Value
Age (yrs) 61.1 ± 12.4 67.1 ± 14.9 0.031
Male sex 103 (60.8%) 29 (70.0%) 0.494
Hypertension 79 (46.7%) 25 (60.5%) 0.968
Hyperlipidemia 80 (47.2%) 23 (55.4%) 0.174
Current smoker 95 (56.3%) 25 (61.5%) 0.711
Diabetes mellitus 26 (15.6%) 8 (19.5%) 0.635
Left ventricular ejection fraction (%) 56.9 ± 8.1 45.5 ± 7.2 0.025
Time to reperfusion (h) 5.4 ± 2.8 6.7 ± 3.2 0.037
WBC count on admission (/mm3) 10484 ± 2716 10562 ± 3075 0.901
CRP on admission (mmol/L) 5.7 ± 4.3 5.9 ± 5.4 0.861
Glucose on admission (mmol/L) 8.7 ± 4.1 12.4 ± 7.5 0.012
Peak creatine kinase levels (IU/L) 320.2 ± 2570 408.9 ± 2117 0.582
LDL‐C (mmol/L) 2.9 ± 0.9 3.5 ± 1.1 0.016
In‐hospital medication
Aspirin 161 (95.2%) 40 (97.3%) 0.404
ACEI or ARB 129 (76.4%) 27 (65.6%) 0.105
Clopidogrel 161 (95.4%) 40 (98.2%) 0.334
Statins 160 (94.5%) 40 (98.2%) 0.662
β‐Blockers 155 (91.5%) 36 (86.6%) 0.434
Infarct vessel
LAD 92 (54.4%) 19 (46.7%) 0.773
LCX 19 (11.2%) 5 (13.3%) 0.984
RCA 58 (34.4%) 16 (40.0%) 0.907
TIMI flow grade 0 at baseline 114 (67.2%) 31 (76.7%) 0.314
Multivessel coronary disease 52 (31.1%) 10 (25.2%) 0.623
Stent implantation 161 (95.2%) 40 (97.3%) 0.944
Inflation pressure (atm) 11.2 ± 2.8 10.8 ± 1.2 0.607
High thrombus burden 59 (35.2%) 30 (73.3%) 0.001
MACCE 9 (5.6%) 7 (16.7%) 0.039

Abbreviations: ACEI, angiotensin‐converting enzyme inhibitor; ARB, angiotensin II receptor blocker; CRP, C‐reactive protein; LAD, left anterior descending artery; LCX, left circumflex artery; LDL‐C, low‐density lipoprotein cholesterol; MACCE, major adverse cardiac and cerebrovascular events; RCA, right coronary artery; TIMI, thrombolysis in myocardial infarction, WBC, white blood count